{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:14:27Z","timestamp":1794453267431,"version":"4.9.1"},"publisher-location":"Totowa, NJ","reference-count":80,"publisher":"Humana Press","isbn-type":[{"value":"9781627035408","type":"print"},{"value":"9781627035415","type":"electronic"}],"license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-62703-541-5_15","type":"book-chapter","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T15:49:15Z","timestamp":1375372155000},"page":"249-266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Methods for Conjugating Antibodies to Nanocarriers"],"prefix":"10.1007","author":[{"given":"Anil","family":"Wagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,1]]},"reference":[{"key":"15_CR00151","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrc3180","volume":"12","author":"A Schroeder","year":"2012","unstructured":"Schroeder A, Heller DA, Winslow MM, Dahlman JE, Pratt GW, Langer R, Jacks T, Anderson DG (2012) Treating metastatic cancer with nanotechnology. Nat Rev Cancer 12:39\u201350","journal-title":"Nat Rev Cancer"},{"key":"15_CR00152","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1517\/17425247.2012.634794","volume":"8","author":"JL Arias","year":"2011","unstructured":"Arias JL (2011) Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging. Expert Opin Drug Deliv 8:1589\u20131608","journal-title":"Expert Opin Drug Deliv"},{"key":"15_CR00153","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505\u2013515","journal-title":"Mol Pharm"},{"key":"15_CR00154","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1021\/mp800049w","volume":"5","author":"SD Li","year":"2008","unstructured":"Li SD, Huang L (2008) Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5:496\u2013504","journal-title":"Mol Pharm"},{"key":"15_CR00155","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1021\/ar200105p","volume":"44","author":"WT Al-Jamal","year":"2011","unstructured":"Al-Jamal WT, Kostarelos K (2011) Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc Chem Res 44:1094\u20131104","journal-title":"Acc Chem Res"},{"key":"15_CR00156","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.nano.2010.05.005","volume":"6","author":"U Kedar","year":"2010","unstructured":"Kedar U, Phutane P, Shidhaye S, Kadam V (2010) Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 6:714\u2013729","journal-title":"Nanomedicine"},{"key":"15_CR00157","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1021\/nl102184c","volume":"10","author":"J Shi","year":"2010","unstructured":"Shi J, Votruba AR, Farokhzad OC, Langer R (2010) Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 10:3223\u20133230","journal-title":"Nano Lett"},{"key":"15_CR00158","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejpb.2008.09.023","volume":"71","author":"S Svenson","year":"2009","unstructured":"Svenson S (2009) Dendrimers as versatile platform in drug delivery applications. Eur J Pharm Biopharm 71:445\u2013462","journal-title":"Eur J Pharm Biopharm"},{"key":"15_CR00159","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ymeth.2008.05.006","volume":"46","author":"DH Levine","year":"2008","unstructured":"Levine DH, Ghoroghchian PP, Freudenberg J, Zhang G, Therien MJ, Greene MI, Hammer DA, Murali R (2008) Polymersomes: a new multi-functional tool for cancer diagnosis and therapy. Methods 46:25\u201332","journal-title":"Methods"},{"key":"15_CR001510","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1073\/pnas.0601755103","volume":"103","author":"OC Farokhzad","year":"2006","unstructured":"Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R (2006) Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 103:6315\u20136320","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR001511","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1073\/pnas.1011379108","volume":"108","author":"S Dhar","year":"2011","unstructured":"Dhar S, Kolishetti N, Lippard SJ, Farokhzad OC (2011) Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo. Proc Natl Acad Sci USA 108:1850\u20131855","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR001512","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1073\/pnas.0914585107","volume":"107","author":"JM Chan","year":"2010","unstructured":"Chan JM, Zhang L, Tong R, Ghosh D, Gao W, Liao G, Yuet KP, Gray D, Rhee JW, Cheng J, Golomb G, Libby P, Langer R, Farokhzad OC (2010) Spatiotemporal controlled delivery of nanoparticles to injured vasculature. Proc Natl Acad Sci USA 107:2213\u20132218","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR001513","doi-asserted-by":"publisher","first-page":"19347","DOI":"10.1073\/pnas.1115945108","volume":"108","author":"JM Chan","year":"2011","unstructured":"Chan JM, Rhee JW, Drum CL, Bronson RT, Golomb G, Langer R, Farokhzad OC (2011) In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proc Natl Acad Sci USA 108:19347\u201319352","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR001514","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1002\/art.30459","volume":"63","author":"TP Thomas","year":"2011","unstructured":"Thomas TP, Goonewardena SN, Majoros IJ, Kotlyar A, Cao Z, Leroueil PR, Baker JR Jr (2011) Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis Rheum 63:2671\u20132680","journal-title":"Arthritis Rheum"},{"key":"15_CR001515","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1021\/nn203190x","volume":"5","author":"X Bosch","year":"2011","unstructured":"Bosch X (2011) Dendrimers to treat rheumatoid arthritis. ACS Nano 5:6779\u20136785","journal-title":"ACS Nano"},{"key":"15_CR001516","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1567-5769(02)00271-0","volume":"3","author":"H Maeda","year":"2003","unstructured":"Maeda H, Fang J, Inutsuka T, Kitamoto Y (2003) Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol 3:319\u2013328","journal-title":"Int Immunopharmacol"},{"key":"15_CR001517","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","volume":"95","author":"SK Hobbs","year":"1998","unstructured":"Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95:4607\u20134612","journal-title":"Proc Natl Acad Sci USA"},{"key":"15_CR001518","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2008.09.074","volume":"133","author":"YH Bae","year":"2009","unstructured":"Bae YH (2009) Drug targeting and tumor heterogeneity. J Control Release 133:2\u20133","journal-title":"J Control Release"},{"key":"15_CR001519","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","volume":"16","author":"DW Northfelt","year":"1998","unstructured":"Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C, Mamelok RD, Henry DH (1998) Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi\u2019s sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 16:2445\u20132451","journal-title":"J Clin Oncol"},{"key":"15_CR001520","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","volume":"23","author":"WJ Gradishar","year":"2005","unstructured":"Gradishar WJ, Tjulandin S, Davidson N, Shaw H, Desai N, Bhar P, Hawkins M, O\u2019Shaughnessy J (2005) Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 23:7794\u20137803","journal-title":"J Clin Oncol"},{"key":"15_CR001521","doi-asserted-by":"publisher","first-page":"11631","DOI":"10.1158\/0008-5472.CAN-05-1093","volume":"65","author":"C Mamot","year":"2005","unstructured":"Mamot C, Drummond DC, Noble CO, Kallab V, Guo Z, Hong K, Kirpotin DB, Park JW (2005) Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res 65:11631\u201311638","journal-title":"Cancer Res"},{"key":"15_CR001522","first-page":"1004","volume":"93","author":"R Srinivasan","year":"2009","unstructured":"Srinivasan R, Marchant RE, Gupta AS (2009) In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes. J Biomed Mater Res A 93:1004\u20131015","journal-title":"J Biomed Mater Res A"},{"key":"15_CR001523","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-04-3921","volume":"65","author":"JF Kukowska-Latallo","year":"2005","unstructured":"Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, Balogh LP, Khan MK, Baker JR Jr (2005) Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 65:5317\u20135324","journal-title":"Cancer Res"},{"key":"15_CR001524","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1021\/ar200054n","volume":"44","author":"J Shi","year":"2011","unstructured":"Shi J, Xiao Z, Kamaly N, Farokhzad OC (2011) Self-assembled targeted nanoparticles: evolution of technologies and bench to bedside translation. Acc Chem Res 44:1123\u20131134","journal-title":"Acc Chem Res"},{"key":"15_CR001525","doi-asserted-by":"publisher","first-page":"11306","DOI":"10.1021\/ja1043177","volume":"132","author":"J Wang","year":"2010","unstructured":"Wang J, Tian S, Petros RA, Napier ME, Desimone JM (2010) The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. J Am Chem Soc 132:11306\u201311313","journal-title":"J Am Chem Soc"},{"key":"15_CR001526","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2010.11.002","volume":"150","author":"AS Manjappa","year":"2011","unstructured":"Manjappa AS, Chaudhari KR, Venkataraju MP, Dantuluri P, Nanda B, Sidda C, Sawant KK, Murthy RS (2011) Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor. J Control Release 150:2\u201322","journal-title":"J Control Release"},{"key":"15_CR001527","first-page":"1999","volume":"63","author":"K Sokolov","year":"2003","unstructured":"Sokolov K, Follen M, Aaron J, Pavlova I, Malpica A, Lotan R, Richards-Kortum R (2003) Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res 63:1999\u20132004","journal-title":"Cancer Res"},{"key":"15_CR001528","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/jps.20098","volume":"93","author":"L Nobs","year":"2004","unstructured":"Nobs L, Buchegger F, Gurny R, Allemann E (2004) Current methods for attaching targeting ligands to liposomes and nanoparticles. J Pharm Sci 93:1980\u20131992","journal-title":"J Pharm Sci"},{"key":"15_CR001529","doi-asserted-by":"crossref","unstructured":"Arruebo M, Valladares M, Gonz\u00e1lez-Fern\u00e1ndez A (2009) Antibody-conjugated nanoparticles for biomedical applications. J Nanomaterials Article ID 439389","DOI":"10.1155\/2009\/439389"},{"key":"15_CR001530","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/protein\/gzq014","volume":"23","author":"S Soga","year":"2010","unstructured":"Soga S, Kuroda D, Shirai H, Kobori M, Hirayama N (2010) Use of amino acid composition to predict epitope residues of individual antibodies. Protein Eng Des Sel 23:441\u2013448","journal-title":"Protein Eng Des Sel"},{"key":"15_CR001531","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijpharm.2009.05.013","volume":"381","author":"P Simard","year":"2009","unstructured":"Simard P, Leroux JC (2009) pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells. Int J Pharm 381:86\u201396","journal-title":"Int J Pharm"},{"key":"15_CR001532","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1477-3155-6-10","volume":"6","author":"M Pereira","year":"2008","unstructured":"Pereira M, Lai EP (2008) Capillary electrophoresis for the characterization of quantum dots after non-selective or selective bioconjugation with antibodies for immunoassay. J Nanobiotechnol 6:10","journal-title":"J Nanobiotechnol"},{"key":"15_CR001533","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1021\/mp900261m","volume":"7","author":"P Simard","year":"2010","unstructured":"Simard P, Leroux JC (2010) In vivo evaluation of pH-sensitive polymer-based immunoliposomes targeting the CD33 antigen. Mol Pharm 7:1098\u20131107","journal-title":"Mol Pharm"},{"key":"15_CR001534","doi-asserted-by":"publisher","first-page":"e25507","DOI":"10.1371\/journal.pone.0025507","volume":"6","author":"T Yokoyama","year":"2011","unstructured":"Yokoyama T, Tam J, Kuroda S, Scott AW, Aaron J, Larson T, Shanker M, Correa AM, Kondo S, Roth JA, Sokolov K, Ramesh R (2011) EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells. PLoS One 6:e25507","journal-title":"PLoS One"},{"key":"15_CR001535","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrd2804","volume":"8","author":"R Jefferis","year":"2009","unstructured":"Jefferis R (2009) Glycosylation as a strategy to improve antibody-based therapeutics. Nat Rev Drug Discov 8:226\u2013234","journal-title":"Nat Rev Drug Discov"},{"key":"15_CR001536","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1021\/bp040016j","volume":"21","author":"R Jefferis","year":"2005","unstructured":"Jefferis R (2005) Glycosylation of recombinant antibody therapeutics. Biotechnol Prog 21:11\u201316","journal-title":"Biotechnol Prog"},{"key":"15_CR001537","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.carres.2010.02.011","volume":"345","author":"KA Kristiansen","year":"2010","unstructured":"Kristiansen KA, Potthast A, Christensen BE (2010) Periodate oxidation of polysaccharides for modification of chemical and physical properties. Carbohydr Res 345:1264\u20131271","journal-title":"Carbohydr Res"},{"key":"15_CR001538","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/bjc.1996.625","volume":"74","author":"D Goren","year":"1996","unstructured":"Goren D, Horowitz AT, Zalipsky S, Woodle MC, Yarden Y, Gabizon A (1996) Targeting of stealth liposomes to erbB-2 (Her\/2) receptor: in vitro and in vivo studies. Br J Cancer 74:1749\u20131756","journal-title":"Br J Cancer"},{"key":"15_CR001539","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0005-2736(95)00138-S","volume":"1239","author":"CB Hansen","year":"1995","unstructured":"Hansen CB, Kao GY, Moase EH, Zalipsky S, Allen TM (1995) Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochim Biophys Acta 1239:133\u2013144","journal-title":"Biochim Biophys Acta"},{"key":"15_CR001540","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0021-9673(01)93763-X","volume":"510","author":"PL Domen","year":"1990","unstructured":"Domen PL, Nevens JR, Mallia AK, Hermanson GT, Klenk DC (1990) Site-directed immobilization of proteins. J Chromatogr 510:293\u2013302","journal-title":"J Chromatogr"},{"key":"15_CR001541","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0361-090X(02)00087-9","volume":"26","author":"GA Koning","year":"2002","unstructured":"Koning GA, Kamps JA, Scherphof GL (2002) Efficient intracellular delivery of 5-fluorodeoxyuridine into colon cancer cells by targeted immunoliposomes. Cancer Detect Prev 26:299\u2013307","journal-title":"Cancer Detect Prev"},{"key":"15_CR001542","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1021\/nn200019s","volume":"5","author":"S Puertas","year":"2011","unstructured":"Puertas S, Batalla P, Moros M, Polo E, Del Pino P, Guisan JM, Grazu V, de la Fuente JM (2011) Taking advantage of unspecific interactions to produce highly active magnetic nanoparticle-antibody conjugates. ACS Nano 5:4521\u20134528","journal-title":"ACS Nano"},{"key":"15_CR001543","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1039\/b701677h","volume":"38","author":"E Valeur","year":"2009","unstructured":"Valeur E, Bradley M (2009) Amide bond formation: beyond the myth of coupling reagents. Chem Soc Rev 38:606\u2013631","journal-title":"Chem Soc Rev"},{"key":"15_CR001544","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1021\/bc800057g","volume":"19","author":"PA McCarron","year":"2008","unstructured":"McCarron PA, Marouf WM, Quinn DJ, Fay F, Burden RE, Olwill SA, Scott CJ (2008) Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells. Bioconjug Chem 19:1561\u20131569","journal-title":"Bioconjug Chem"},{"key":"15_CR001545","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1039\/c0pp00266f","volume":"10","author":"AJ Bullous","year":"2011","unstructured":"Bullous AJ, Alonso CM, Boyle RW (2011) Photosensitiser-antibody conjugates for photodynamic therapy. Photochem Photobiol Sci 10:721\u2013750","journal-title":"Photochem Photobiol Sci"},{"key":"15_CR001546","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(90)90267-D","volume":"185","author":"Z Grabarek","year":"1990","unstructured":"Grabarek Z, Gergely J (1990) Zero-length crosslinking procedure with the use of active esters. Anal Biochem 185:131\u2013135","journal-title":"Anal Biochem"},{"key":"15_CR001547","doi-asserted-by":"publisher","first-page":"9145","DOI":"10.1016\/j.biomaterials.2010.08.053","volume":"31","author":"Y Liu","year":"2010","unstructured":"Liu Y, Li K, Liu B, Feng SS (2010) A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials 31:9145\u20139155","journal-title":"Biomaterials"},{"key":"15_CR001548","doi-asserted-by":"publisher","first-page":"5737","DOI":"10.1016\/j.biomaterials.2009.07.008","volume":"30","author":"S Acharya","year":"2009","unstructured":"Acharya S, Dilnawaz F, Sahoo SK (2009) Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials 30:5737\u20135750","journal-title":"Biomaterials"},{"key":"15_CR001549","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.nano.2011.03.009","volume":"7","author":"G Arya","year":"2011","unstructured":"Arya G, Vandana M, Acharya S, Sahoo SK (2011) Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy. Nanomedicine 7:859\u2013870","journal-title":"Nanomedicine"},{"key":"15_CR001550","first-page":"3154","volume":"63","author":"C Mamot","year":"2003","unstructured":"Mamot C, Drummond DC, Greiser U, Hong K, Kirpotin DB, Marks JD, Park JW (2003) Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells. Cancer Res 63:3154\u20133161","journal-title":"Cancer Res"},{"key":"15_CR001551","doi-asserted-by":"publisher","first-page":"6449","DOI":"10.1021\/ac900815z","volume":"81","author":"C Chumsae","year":"2009","unstructured":"Chumsae C, Gaza-Bulseco G, Liu H (2009) Identification and localization of unpaired cysteine residues in monoclonal antibodies by fluorescence labeling and mass spectrometry. Anal Chem 81:6449\u20136457","journal-title":"Anal Chem"},{"key":"15_CR001552","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1021\/bp025511z","volume":"18","author":"W Zhang","year":"2002","unstructured":"Zhang W, Czupryn MJ (2002) Free sulfhydryl in recombinant monoclonal antibodies. Biotechnol Prog 18:509\u2013513","journal-title":"Biotechnol Prog"},{"key":"15_CR001553","doi-asserted-by":"publisher","first-page":"6976","DOI":"10.1021\/ja0705994","volume":"129","author":"SL Cohen","year":"2007","unstructured":"Cohen SL, Price C, Vlasak J (2007) Beta-elimination and peptide bond hydrolysis: two distinct mechanisms of human IgG1 hinge fragmentation upon storage. J Am Chem Soc 129:6976\u20136977","journal-title":"J Am Chem Soc"},{"key":"15_CR001554","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1021\/bc900295v","volume":"21","author":"T Ji","year":"2010","unstructured":"Ji T, Muenker MC, Papineni RV, Harder JW, Vizard DL, McLaughlin WE (2010) Increased sensitivity in antigen detection with fluorescent latex nanosphere-IgG antibody conjugates. Bioconjug Chem 21:427\u2013435","journal-title":"Bioconjug Chem"},{"key":"15_CR001555","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1021\/ac100468k","volume":"82","author":"A Kausaite-Minkstimiene","year":"2010","unstructured":"Kausaite-Minkstimiene A, Ramanaviciene A, Kirlyte J, Ramanavicius A (2010) Comparative study of random and oriented antibody immobilization techniques on the binding capacity of immunosensor. Anal Chem 82:6401\u20136408","journal-title":"Anal Chem"},{"key":"15_CR001556","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/protein\/gzm015","volume":"20","author":"DP Humphreys","year":"2007","unstructured":"Humphreys DP, Heywood SP, Henry A, Ait-Lhadj L, Antoniw P, Palframan R, Greenslade KJ, Carrington B, Reeks DG, Bowering LC, West S, Brand HA (2007) Alternative antibody Fab\u2019 fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering. Protein Eng Des Sel 20:227\u2013234","journal-title":"Protein Eng Des Sel"},{"key":"15_CR001557","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/10611860600691049","volume":"14","author":"C Mamot","year":"2006","unstructured":"Mamot C, Ritschard R, Kung W, Park JW, Herrmann R, Rochlitz CF (2006) EGFR-targeted immunoliposomes derived from the monoclonal antibody EMD72000 mediate specific and efficient drug delivery to a variety of colorectal cancer cells. J Drug Target 14:215\u2013223","journal-title":"J Drug Target"},{"key":"15_CR001558","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0304-3835(03)00099-5","volume":"197","author":"C Brignole","year":"2003","unstructured":"Brignole C, Marimpietri D, Gambini C, Allen TM, Ponzoni M, Pastorino F (2003) Development of Fab\u2019 fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma. Cancer Lett 197:199\u2013204","journal-title":"Cancer Lett"},{"key":"15_CR001559","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/0005-2736(86)90147-1","volume":"856","author":"K Hashimoto","year":"1986","unstructured":"Hashimoto K, Loader JE, Kinsky SC (1986) Iodoacetylated and biotinylated liposomes: effect of spacer length on sulfhydryl ligand binding and avidin precipitability. Biochim Biophys Acta 856:556\u2013565","journal-title":"Biochim Biophys Acta"},{"key":"15_CR001560","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1021\/mp900316a","volume":"7","author":"CM Hu","year":"2010","unstructured":"Hu CM, Kaushal S, Tran Cao HS, Aryal S, Sartor M, Esener S, Bouvet M, Zhang L (2010) Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. Mol Pharm 7:914\u2013920","journal-title":"Mol Pharm"},{"key":"15_CR001561","doi-asserted-by":"publisher","first-page":"13888","DOI":"10.1021\/la203273p","volume":"27","author":"DA East","year":"2011","unstructured":"East DA, Mulvihill DP, Todd M, Bruce IJ (2011) QD-antibody conjugates via carbodiimide-mediated coupling: a detailed study of the variables involved and a possible new mechanism for the coupling reaction under basic aqueous conditions. Langmuir 27:13888\u201313896","journal-title":"Langmuir"},{"key":"15_CR001562","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1039\/c1jm14683a","volume":"22","author":"D Kozlova","year":"2012","unstructured":"Kozlova D, Chernousova S, Knuschke T, Buer J, Westendorf AM, Epple M (2012) Cell targeting by antibody-functionalized calcium phosphate nanoparticles. J Mater Chem 22:396\u2013404","journal-title":"J Mater Chem"},{"key":"15_CR001563","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0005-2736(00)00305-9","volume":"1509","author":"M Mercadal","year":"2000","unstructured":"Mercadal M, Domingo JC, Petriz J, Garcia J, de Madariaga MA (2000) Preparation of immunoliposomes bearing poly(ethylene glycol)-coupled monoclonal antibody linked via a cleavable disulfide bond for ex vivo applications. Biochim Biophys Acta 1509:299\u2013310","journal-title":"Biochim Biophys Acta"},{"key":"15_CR001564","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0169-409X(02)00179-5","volume":"55","author":"G Saito","year":"2003","unstructured":"Saito G, Swanson JA, Lee KD (2003) Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv Drug Deliv Rev 55:199\u2013215","journal-title":"Adv Drug Deliv Rev"},{"key":"15_CR001565","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1021\/bi00618a013","volume":"17","author":"R Jue","year":"1978","unstructured":"Jue R, Lambert JM, Pierce LR, Traut RR (1978) Addition of sulfhydryl groups to Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate). Biochemistry 17:5399\u20135406","journal-title":"Biochemistry"},{"key":"15_CR001566","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1021\/bc8002452","volume":"19","author":"MG Anhorn","year":"2008","unstructured":"Anhorn MG, Wagner S, Kreuter J, Langer K, von Briesen H (2008) Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles. Bioconjug Chem 19:2321\u20132331","journal-title":"Bioconjug Chem"},{"key":"15_CR001567","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1016\/j.vaccine.2007.04.029","volume":"25","author":"A Badiee","year":"2007","unstructured":"Badiee A, Davies N, McDonald K, Radford K, Michiue H, Hart D, Kato M (2007) Enhanced delivery of immunoliposomes to human dendritic cells by targeting the multilectin receptor DEC-205. Vaccine 25:4757\u20134766","journal-title":"Vaccine"},{"key":"15_CR001568","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1039\/an9851001073","volume":"110","author":"Y-P Wu","year":"1985","unstructured":"Wu Y-P, Miller LG, Danielson ND (1985) Determination of ethylene glycol using periodate oxidation and liquid chromatography. Analyst 110:1073\u20131076","journal-title":"Analyst"},{"key":"15_CR001569","doi-asserted-by":"publisher","first-page":"474012","DOI":"10.1088\/0022-3727\/43\/47\/474012","volume":"43","author":"S Puertas","year":"2010","unstructured":"Puertas S, Moros M, Fern\u00e1ndez-Pacheco R, Ibarra MR, Graz\u00fa V, de la Fuente JM (2010) Designing novel nano-immunoassays: antibody orientation versus sensitivity. J Phys D: Appl Phys 43:474012","journal-title":"J Phys D: Appl Phys"},{"key":"15_CR001570","doi-asserted-by":"publisher","first-page":"8774","DOI":"10.1021\/ac9012122","volume":"81","author":"PC Lin","year":"2009","unstructured":"Lin PC, Chen SH, Wang KY, Chen ML, Adak AK, Hwu JR, Chen YJ, Lin CC (2009) Fabrication of oriented antibody-conjugated magnetic nanoprobes and their immunoaffinity application. Anal Chem 81:8774\u20138782","journal-title":"Anal Chem"},{"key":"15_CR001571","first-page":"1","volume":"3","author":"GR Grimsley","year":"2004","unstructured":"Grimsley GR, Pace CN (2004) Spectrophotometric determination of protein concentration. Curr Protoc Protein Sci Chapter 3:Unit 3.1","journal-title":"Curr Protoc Protein Sci Chapter"},{"key":"15_CR001572","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF02798427","volume":"14","author":"L Peng","year":"1987","unstructured":"Peng L, Calton GJ, Burnett JW (1987) Effect of borohydride reduction on antibodies. Appl Biochem Biotechnol 14:91\u201399","journal-title":"Appl Biochem Biotechnol"},{"key":"15_CR001573","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0003-2697(84)90388-9","volume":"139","author":"WS Wong","year":"1984","unstructured":"Wong WS, Osuga DT, Feeney RE (1984) Pyridine borane as a reducing agent for proteins. Anal Biochem 139:58\u201367","journal-title":"Anal Biochem"},{"key":"15_CR001574","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.3390\/s91109332","volume":"9","author":"DK Tiwari","year":"2009","unstructured":"Tiwari DK, Tanaka S, Inouye Y, Yoshizawa K, Watanabe TM, Jin T (2009) Synthesis and characterization of Anti-HER2 antibody conjugated CdSe\/CdZnS quantum dots for fluorescence imaging of breast cancer cells. Sensors (Basel) 9:9332\u20139364","journal-title":"Sensors (Basel)"},{"key":"15_CR001575","volume-title":"Bioconjugate techniques","author":"G Hermanson","year":"2008","unstructured":"Hermanson G (2008) Bioconjugate techniques, 2nd edn. Academic, London","edition":"2"},{"key":"15_CR001576","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1021\/bi00845a044","volume":"7","author":"MH Freedman","year":"1968","unstructured":"Freedman MH, Grossberg AL, Pressman D (1968) The effects of complete modification of amino groups on the antibody activity of antihapten antibodies. Reversible inactivation with maleic anhydride. Biochemistry 7:1941\u20131950","journal-title":"Biochemistry"},{"key":"15_CR001577","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1021\/bc9004975","volume":"21","author":"J Lee","year":"2010","unstructured":"Lee J, Choi Y, Kim K, Hong S, Park HY, Lee T, Cheon GJ, Song R (2010) Characterization and cancer cell specific binding properties of anti-EGFR antibody conjugated quantum dots. Bioconjug Chem 21:940\u2013946","journal-title":"Bioconjug Chem"},{"key":"15_CR001578","doi-asserted-by":"publisher","first-page":"15059","DOI":"10.1074\/jbc.M311480200","volume":"279","author":"F Vinci","year":"2004","unstructured":"Vinci F, Catharino S, Frey S, Buchner J, Marino G, Pucci P, Ruoppolo M (2004) Hierarchical formation of disulfide bonds in the immunoglobulin Fc fragment is assisted by protein-disulfide isomerase. J Biol Chem 279:15059\u201315066","journal-title":"J Biol Chem"},{"key":"15_CR001579","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00216-002-1347-2","volume":"373","author":"CK Riener","year":"2002","unstructured":"Riener CK, Kada G, Gruber HJ (2002) Quick measurement of protein sulfhydryls with Ellman\u2019s reagent and with 4,4'-dithiodipyridine. Anal Bioanal Chem 373:266\u2013276","journal-title":"Anal Bioanal Chem"},{"key":"15_CR001580","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0165-022X(93)90042-M","volume":"26","author":"J Woodward","year":"1993","unstructured":"Woodward J, Tate J, Herrmann PC, Evans BR (1993) Comparison of Ellman\u2019s reagent with N-(1-pyrenyl)maleimide for the determination of free sulfhydryl groups in reduced cellobiohydrolase I from Trichoderma reesei. J Biochem Biophys Methods 26:121\u2013129","journal-title":"J Biochem Biophys Methods"}],"container-title":["Methods in Molecular Biology","Antibody-Drug Conjugates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-541-5_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T09:29:23Z","timestamp":1676798963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-541-5_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"ISBN":["9781627035408","9781627035415"],"references-count":80,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-541-5_15","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-62703-541-5","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"1 July 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}